Ya-Jung Shih

603 total citations
19 papers, 481 citations indexed

About

Ya-Jung Shih is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ya-Jung Shih has authored 19 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Ya-Jung Shih's work include Cancer, Stress, Anesthesia, and Immune Response (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Ya-Jung Shih is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Ya-Jung Shih collaborates with scholars based in Taiwan, United States and Italy. Ya-Jung Shih's co-authors include Hung‐Yun Lin, Yu‐Tang Chin, Paul J. Davis, Yi‐Ru Chen, Yu‐Chen S. H. Yang, Jacqueline Whang‐Peng, Yih Ho, Chun A. Changou, Kuan Wang and André Wendindondé Nana and has published in prestigious journals such as Nutrients, Food and Chemical Toxicology and Oncotarget.

In The Last Decade

Ya-Jung Shih

19 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ya-Jung Shih Taiwan 15 184 137 85 75 56 19 481
Guangyu Dong China 14 346 1.9× 53 0.4× 122 1.4× 80 1.1× 30 0.5× 20 639
Su‐Jin Yoo South Korea 13 208 1.1× 46 0.3× 118 1.4× 59 0.8× 14 0.3× 31 494
Sajad Dehnavi Iran 15 268 1.5× 57 0.4× 148 1.7× 100 1.3× 7 0.1× 37 612
Shuangnian Xu China 17 354 1.9× 131 1.0× 106 1.2× 118 1.6× 59 1.1× 47 749
Fuqiang Feng China 12 247 1.3× 72 0.5× 61 0.7× 123 1.6× 12 0.2× 20 440
Lianhua Zhu China 11 168 0.9× 94 0.7× 93 1.1× 66 0.9× 12 0.2× 16 352
Patrycja Sosińska Poland 15 244 1.3× 127 0.9× 77 0.9× 87 1.2× 43 0.8× 29 564
Omar Rahal United States 12 331 1.8× 200 1.5× 96 1.1× 131 1.7× 15 0.3× 20 623
Arisa Imsumran Thailand 15 295 1.6× 168 1.2× 26 0.3× 157 2.1× 7 0.1× 26 581
Hideharu Fukao Japan 12 148 0.8× 58 0.4× 49 0.6× 160 2.1× 26 0.5× 34 426

Countries citing papers authored by Ya-Jung Shih

Since Specialization
Citations

This map shows the geographic impact of Ya-Jung Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya-Jung Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya-Jung Shih more than expected).

Fields of papers citing papers by Ya-Jung Shih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya-Jung Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya-Jung Shih. The network helps show where Ya-Jung Shih may publish in the future.

Co-authorship network of co-authors of Ya-Jung Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Ya-Jung Shih. A scholar is included among the top collaborators of Ya-Jung Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya-Jung Shih. Ya-Jung Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cheng, Tsai-Mu, Roberto De Luca, Jens Z. Pedersen, et al.. (2021). Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy. Cells. 10(7). 1684–1684. 52 indexed citations
2.
Ho, Yih, Yu‐Tang Chin, Sheng‐Yang Lee, et al.. (2019). NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells. Food and Chemical Toxicology. 136. 111092–111092. 31 indexed citations
3.
Chen, Yi‐Ru, Yu‐Tang Chin, Ya-Jung Shih, et al.. (2019). Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells. Food and Chemical Toxicology. 132. 110693–110693. 28 indexed citations
4.
Ho, Yih, Shwu-Huey Wang, Yi‐Ru Chen, et al.. (2019). Leptin-derived peptides block leptin-induced proliferation by reducing expression of pro-inflammatory genes in hepatocellular carcinoma cells. Food and Chemical Toxicology. 133. 110808–110808. 10 indexed citations
5.
Yang, Yu‐Chen S. H., Ya-Jung Shih, James A. Bennett, et al.. (2019). Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers. Nutrients. 11(12). 2979–2979. 14 indexed citations
6.
Lin, Chia-Cheng, Yu‐Tang Chin, Ya-Jung Shih, et al.. (2019). Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells. Journal of Dental Sciences. 14(3). 255–262. 27 indexed citations
7.
Lin, Hung‐Yun, Yih Ho, Yu‐Tang Chin, et al.. (2018). Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway. Marine Drugs. 16(12). 489–489. 13 indexed citations
8.
Chin, Yu‐Tang, Yih Ho, Szu‐Yi Chou, et al.. (2018). Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells. Food and Chemical Toxicology. 120. 1–11. 19 indexed citations
9.
Nana, André Wendindondé, Szu‐Yuan Wu, Yu‐Chen S. H. Yang, et al.. (2018). Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers. Hormones and Cancer. 9(5). 349–360. 22 indexed citations
10.
Ho, Yih, Li‐Hsuan Wang, Yu‐Tang Chin, et al.. (2018). Inhibitory Effect of Anoectochilus formosanus Extract on Hyperglycemia-Related PD-L1 Expression and Cancer Proliferation. Frontiers in Pharmacology. 9. 807–807. 26 indexed citations
11.
Chin, Yu‐Tang, Po‐Li Wei, Yih Ho, et al.. (2018). Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells. Endocrine Related Cancer. 25(5). 533–545. 48 indexed citations
12.
Chin, Yu‐Tang, Ya-Jung Shih, André Wendindondé Nana, et al.. (2018). Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer. Hormones and Cancer. 9(3). 156–165. 23 indexed citations
13.
Chang, Tung‐Cheng, Yu‐Tang Chin, André Wendindondé Nana, et al.. (2018). Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation. Hormones and Cancer. 9(6). 420–432. 25 indexed citations
14.
Ho, Yih, Yu‐Chen S. H. Yang, Yu‐Tang Chin, et al.. (2018). Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R. Food and Chemical Toxicology. 120. 346–355. 36 indexed citations
15.
Lin, Hung‐Yun, Yu‐Tang Chin, Ya-Jung Shih, et al.. (2018). In tumor cells, thyroid hormone analogues non-immunologically regulate PD-L1 and PD-1 accumulation that is anti-apoptotic. Oncotarget. 9(75). 34033–34037. 13 indexed citations
16.
Chin, Yu‐Tang, Meng-Ti Hsieh, Ya-Jung Shih, et al.. (2017). Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells. Journal of Biomedical Science. 24(1). 51–51. 25 indexed citations
17.
Nana, André Wendindondé, Yu‐Tang Chin, Yih Ho, et al.. (2017). Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer. Endocrine Related Cancer. 25(3). 279–293. 27 indexed citations
18.
Ho, Yih, Hsuan‐Liang Liu, Ya-Jung Shih, et al.. (2017). Biological Mechanisms by Which Antiproliferative Actions of Resveratrol Are Minimized. Nutrients. 9(10). 1046–1046. 10 indexed citations
19.
Chin, Yu‐Tang, Meng-Ti Hsieh, Yu‐Chen S. H. Yang, et al.. (2016). 2,3,5,4′-Tetrahydroxystilbene-2-O-β-glucoside Isolated from Polygoni Multiflori Ameliorates the Development of Periodontitis. Mediators of Inflammation. 2016. 1–12. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangyu Dong Breakdown of academic impact, for papers by Su‐Jin Yoo Breakdown of academic impact, for papers by Sajad Dehnavi Breakdown of academic impact, for papers by Shuangnian Xu Breakdown of academic impact, for papers by Fuqiang Feng Breakdown of academic impact, for papers by Lianhua Zhu Breakdown of academic impact, for papers by Patrycja Sosińska Breakdown of academic impact, for papers by Omar Rahal Breakdown of academic impact, for papers by Arisa Imsumran Breakdown of academic impact, for papers by Hideharu Fukao
Rankless by CCL
2026